Mary D. Bareford, Ph.D. - Publications

Affiliations: 
2012 Biochemistry Virginia Commonwealth University, Richmond, VA, United States 
Area:
Biochemistry, Molecular Biology, Cell Biology, Oncology

10 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Cruickshanks N, Roberts JL, Bareford MD, Tavallai M, Poklepovic A, Booth L, Spiegel S, Dent P. Differential regulation of autophagy and cell viability by ceramide species. Cancer Biology & Therapy. 16: 733-42. PMID 25803131 DOI: 10.1080/15384047.2015.1026509  0.63
2012 Bareford MD, Hamed HA, Allegood J, Cruickshanks N, Poklepovic A, Park MA, Ogretmen B, Spiegel S, Grant S, Dent P. Sorafenib and pemetrexed toxicity in cancer cells is mediated via SRC-ERK signaling. Cancer Biology & Therapy. 13: 793-803. PMID 22673740 DOI: 10.4161/Cbt.20562  0.731
2012 Cruickshanks N, Hamed HA, Bareford MD, Poklepovic A, Fisher PB, Grant S, Dent P. Lapatinib and obatoclax kill tumor cells through blockade of ERBB1/3/4 and through inhibition of BCL-XL and MCL-1. Molecular Pharmacology. 81: 748-58. PMID 22357666 DOI: 10.1124/Mol.112.077586  0.751
2012 Booth LA, Cruickshanks N, Tang Y, Bareford MD, Hamed HA, Fisher PB, Grant S, Dent P. Current advances in ER stress intervention therapies Endoplasmic Reticulum Stress in Health and Disease. 2147483647: 429-445. DOI: 10.1007/978-94-007-4351-9_19  0.576
2011 Bareford MD, Hamed HA, Tang Y, Cruickshanks N, Burow ME, Fisher PB, Moran RG, Nephew KP, Grant S, Dent P. Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells. Autophagy. 7: 1261-2. PMID 21814046 DOI: 10.4161/Auto.7.10.17029  0.754
2011 Mitchell C, Hamed HA, Cruickshanks N, Tang Y, Bareford MD, Hubbard N, Tye G, Yacoub A, Dai Y, Grant S, Dent P. Simultaneous exposure of transformed cells to SRC family inhibitors and CHK1 inhibitors causes cell death. Cancer Biology & Therapy. 12: 215-28. PMID 21642769 DOI: 10.4161/Cbt.12.3.16218  0.701
2011 Bareford MD, Park MA, Yacoub A, Hamed HA, Tang Y, Cruickshanks N, Eulitt P, Hubbard N, Tye G, Burow ME, Fisher PB, Moran RG, Nephew KP, Grant S, Dent P. Sorafenib enhances pemetrexed cytotoxicity through an autophagy-dependent mechanism in cancer cells. Cancer Research. 71: 4955-67. PMID 21622715 DOI: 10.1158/0008-5472.Can-11-0898  0.756
2011 Bareford MD, Hamed HA, Park M, Grant S, Fisher P, Dent P. Abstract 5390: A serotype 5/3 adenovirus expressing MDA-7/IL-24 infects renal carcinoma cells and promotes toxicity of agents that increase ROS and ceramide levels Cancer Research. 71: 5390-5390. DOI: 10.1158/1538-7445.Am2011-5390  0.679
2011 Hamed HA, Mitchell C, Dent P, Yacoub A, Tye G, Bareford MD. Abstract 5383: Inhibition of MCL-1 in mammary and CNS tumor cells promotes cell deathin vitroandin vivo Cancer Research. 71: 5383-5383. DOI: 10.1158/1538-7445.Am2011-5383  0.736
2010 Mitchell C, Yacoub A, Hossein H, Martin AP, Bareford MD, Eulitt P, Yang C, Nephew KP, Dent P. Inhibition of MCL-1 in breast cancer cells promotes cell death in vitro and in vivo. Cancer Biology & Therapy. 10: 903-17. PMID 20855960 DOI: 10.4161/Cbt.10.9.13273  0.763
Show low-probability matches.